Study on the detection of leprosy reactions and the effect of prednisone on various nerves, Indonesia

Leprosy Review

Volumn 68, Issue 3, 1997, Pages 225-232

  Bernink, E H M ^a,b   Voskens, J E J ^a  

^a Provincial Department of Health   (Indonesia)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PREDNISONE;

ARTICLE; COHORT ANALYSIS; HEALTH CARE PERSONNEL; HEALTH CENTER; HUMAN; INDONESIA; LEPROSY; LEPROSY CONTROL; MAJOR CLINICAL STUDY; NEURITIS; PRACTICE GUIDELINE; RETROSPECTIVE STUDY;

EID: 0030690382     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.19970031     Document Type: Article

References (22)

1. Van Brakel WH, Khawas IB, Lucas SB. Reactions in leprosy: an epidemiological study of 386 patients in West Nepal. Lepr Rev, 1994; 65.
2. Becx-Bleumink M, Berhe D. Occurrence of Reactions, their diagnosis and management in leprosy patients with multidrug therapy. Int J Lepr, 1992; 60, 00.
3. Brandsma JW. Intrinsic minus hand: (patho)kinesiology, rehabilitation and reconstruction. Doctorate theses. Published by: de Brandaen, Amersfoort, 1993.
4. Brandsma JW. Terminology in leprosy rehabilitation and guidelines for nerve function assessment. Trop Geograph Med, 1994; Vol 46: No 2, 00.
5. ILEP. Prevention of Disability: Guidelines for Leprosy Control Programes, March 1993.
6. Watson JM. Preventing disability in leprosy patients. TLMI, 1986.
7. Srinivasam H. Prevention of disabilities in patients with leprosy. WHO. 1993.
8. Van Brakel WH. Peripheral neuropathy in leprosy. The continuing Challenge. Doctorate thesis. The Hague, 1984.
9. Watson JM. Essential action to minimise disability in leprosy patients. The Leprosy Mission International. 1988.
10. Naafs B, Dagne T. Sensory testing: a sensitive method in the follow-up of nerve involvement. Int J Lepr, 1977; 45: 364-8.
11. Touw-Langendijk EMJ, Brandsma JW, Andersen JG. Treatment of ulnar and median nerve function loss in borderline leprosy. Lepr Rev, 1984; 55: 41-6.
12. Brandsma JW, Schreuders T, Birke J, Piefer A, Oostendorp R. Reliability of manual muscle strength testing in the evaluation of peripheral nerve dysfunction in leprosy patients. Paper presented at the 14th International Leprosy Congress, Florida, 1994.
13. Naafs B, Wheate HW. The time interval between the start of anti-leprosy treatment and the development of reactions in borderline patients. Lepr Rev, 1978; 49: 153-157.
14. Summers A. Leprosy for field staff. TLMI, 1993.
15. Rose P, Waters MFR. Reversal Reactions in leprosy and their management. Lepr Rev, 1991; 62: 113-121.
16. Imkamp FMJH. Standardized schemes for steroid treatment in ENL and reversal reactions. Int J Lepr, 1985; 53: 313-317.
17. Pearson JMH. The evaluation of nerve damage in leprosy. Lepr Rev, 1982; 53: 119-130.
18. Kiran KU, Hogeweg M, Suneetha S. Treatment of recent facial nerve damage with lagophthalmos, using a semistandardized steroid regimen. Lepr Rev, 1991; 62: 150-154.
19. World Health Organization Report of the consultation on disability prevention and rehabilitation in leprosy, Geneva, 1987. WHO/CDS/LEP/87.3.
20. Pearson JMH. The use of corticosteroids in leprosy. Lepr Rev, 1981; 52: 293-298.
21. De Soldenhoff R. Protocol for the Management of Reactions in the Field in Bauchi State, Nigeria. Unpublished.
22. A guide to eliminating leprosy as a public health problem (WHO 1995).